UNSPSC 85881728: Tomographic (tomo) nuclear medicine imaging of spleen using technetium 99m (tc-99m)

This classification denotes the group of activities that yields an intervention or procedure of tomographic (tomo) nuclear medicine imaging of spleen using technetium 99m (tc-99m). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code C7221ZZ

UNSPSC 85881728 Tomographic nuclear medicine imaging of spleen using technetium 99m (tc-99m) is a Commodity code that shows minimal recent activity aligned with its specific clinical scope in state and local procurement. The three most recently posted opportunities—a diagnostic imaging PACS system implementation at San Mateo Medical Center, special education contracted services at Birdville Independent School District, and a temporary health professional staffing pool at Santa Clara Health System—do not represent procurements of tomographic nuclear medicine imaging services under this code. The PACS solicitation involves enterprise imaging architecture and data migration rather than nuclear medicine imaging procedures; the education and health professional staffing opportunities are unrelated to nuclear medicine diagnostics entirely. State and local buyers operating this code would typically solicit nuclear medicine imaging capacity, equipment, or services where spleen imaging is part of a broader diagnostic imaging portfolio, but no such opportunities appear in the recent pipeline.

The code shows no identifiable recent procurement activity from state departments, county health systems, school districts, or municipalities that are actively seeking tomographic nuclear medicine imaging services. With no representative recent solicitations matching the code's scope, no geographic concentration can be established, and no issuing-body pattern emerges. Firms pursuing state and local opportunities under this code should monitor regional health systems and hospital networks in California and Texas—where the recent health care–related procurement volume concentrates—but current market signals do not indicate active demand for nuclear medicine imaging services specifically.